AstraZeneca PLC (LON:AZN)
11,210
-48 (-0.43%)
Sep 24, 2025, 6:19 PM BST
AstraZeneca Market Cap
AstraZeneca has a market cap or net worth of 173.83 billion as of September 24, 2025. Its market cap has decreased by -5.99% in one year.
Market Cap
173.83B
Enterprise Value
192.75B
Revenue
41.24B
Ranking
n/a
PE Ratio
28.93
Stock Price
11,210.00
Market Cap Chart
Since May 28, 1993, AstraZeneca's market cap has increased from 4.55B to 173.83B, an increase of 3,720.16%. That is a compound annual growth rate of 11.92%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 24, 2025 | 173.83B | 7.11% |
Dec 31, 2024 | 162.29B | -1.22% |
Dec 29, 2023 | 164.29B | -5.48% |
Dec 30, 2022 | 173.83B | 29.30% |
Dec 31, 2021 | 134.44B | 39.83% |
Dec 31, 2020 | 96.14B | -3.67% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
GSK plc | 60.24B |
Haleon | 30.25B |
Smith & Nephew | 11.86B |
ConvaTec Group | 4.69B |
Hikma Pharmaceuticals | 3.58B |
HUTCHMED (China) | 2.19B |
Genus | 1.62B |
Oxford Nanopore Technologies | 1.52B |